Medizone Intl. (fka MZEIQ)

[Soleantu]

I e-mailed John Pentony yesterday and this is his reply.

Hi Soleantu,

I am mixing in my answers in red with your questions in black:

I am a shareholder that is a bit concerned with the recent sell-offs and the share price that keeps
on dropping. I strongly believe that this is a reaction of shareholders not hearing any news for long
periods of time.

We will likely have more information relatively soon, we are closer to being able to share a lot more.

Since Asepticsure was approved in Canada, it would be nice to know how many (if any) Asepticsure Units have been sold by Woodwyant? Is there any sales record you can share? What about the US EPA approval. Any news on that?

I am not sure of the exact number in Canada. I am asking Ed and others what the Canadian number is, and what the number outside of the US. I hope to get that to you soon.

EPA – We are getting closer. Right now they have not asked for additional test and have not asked additional formal questions. I am told that the we tested in the most accurate, best way possible. I hope this answers the question.


Also, although the company website is nice, it is important for us shareholders to see company news hit the news wires that reach current and prospective investors.

You are right that the wires are the best source for releasing news. We totally agree. The reason we do Chairmans Updates on the site is that not everything rises to what we legally things requires (maybe justifies is a better word) a press release. Our Chairman usually gives a wider update that contains several items. Sometimes that is too many different topics for a standard press release.

Thanks,


John Pentony




John Pentony
Investor Relations for Medizone International (MZEI)

[e-mail]

Office: 415-331-0202
Cell: 469-358-5200
Skype: john.pentony

Medizone on the Web:
http://medizoneint.com

Medizone's IR Information:
http://www.medizoneint.com/investor-relations